In prostate cancer mouse models expressing high levels of MYC, treatment with metformin has been shown to decrease MYC levels both in vivo and in vitro, inhibiting the growth of prostate cancer cells while minimally inhibiting growth of normal prostatic epithelial cells [47]. The gene discussed is MYC; the disease is prostate cancer.